Encouraging Data Encourage More Research on Optimal Medical Therapy for Patients With HFrEF

Aldo Maggioni

doi:10.1016/j.jchf.2024.06.012

Related publications

Letter2017

Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy

Javaid Iqbal, Patrick W. Serruys

Annals of Translational Medicine

Article2021

Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization

Hideyuki Kawashima, Patrick W. Serruys, Masafumi Ono, Hironori Hara, Neil O’Leary, Michael J. Mack, David R. Holmes, Marie‐Claude Morice, Stuart J. Head, A. Pieter Kappetein, Daniel J.F.M. Thuijs, Milan Milojevic, Thilo Noack, Friedrich‐Wilhelm Mohr, Piroze Davierwala, Faisal Sharif, John W. McEvoy, Yoshinobu Onuma

Journal of the American College of Cardiology

Article2009

What Is the Optimal Therapy for Patients with H5N1 Influenza?

Sir Nicholas White, Robert G. Webster, Elena A. Govorkova, Timothy M. Uyeki

PLoS Medicine

Article2015

Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting

Javaid Iqbal, Yao‐Jun Zhang, David R. Holmes, Marie‐Claude Morice, Michael J. Mack, A. Pieter Kappetein, Ted Feldman, E Ståhle, Javier Escaned, Adrian Banning, Julian Gunn, Antonio Colombo, Ewout W. Steyerberg, Friedrich W. Mohr, Patrick W. Serruys

Circulation

Article2016

Real-world cost effectiveness of MitraClip combined with Medical Therapy Versus Medical therapy alone in patients with moderate or severe mitral regurgitation

Patrizio Armeni, Paola Roberta Boscolo, Rosanna Tarricone, Davide Capodanno, Aldo Maggioni, Carmelo Grasso, Corrado Tamburino, Francesco Maisano

Encouraging Data Encourage More Research on Optimal Medical Therapy for Patients With HFrEF

Discussion(0)